Effects of Standard and Individualized Dialysate Sodium in Chronic Hemodialysis Patients Upon Echocardiography
Natasha Eftimovska-Otovikj1, Olivera Stojceva-Taneva2, Natasha Petkovikj3
1General City Hospital 8th September, Department of nephrology, 1000 Skopje, RN Macedonia.
Insights
Individualized dialysis sodium prescription effectively reduced blood pressure and interdialytic weight gain in hypertensive patients. This approach also decreased heart hypertrophy in hemodialysis patients by managing fluid overload.
Area of Science:
- Nephrology
- Cardiology
- Biomedical Engineering
Background:
- Hemodialysis (HD) patients often experience fluid overload and cardiac complications.
- Standard dialysate sodium may not be optimal for all patients.
- Individualizing sodium prescription is a potential strategy to improve outcomes.
Purpose of the Study:
- To assess the impact of individualized dialysate sodium on echocardiographic changes in hemodialysis patients.
- To evaluate the effects of tailored sodium concentrations on blood pressure and fluid balance.
Main Methods:
- 77 chronic hemodialysis patients participated in a two-phase study.
- Phase 1: Standard dialysate sodium (138 mmol/L). Phase 2: Individualized sodium based on pre-HD serum sodium.
- Echocardiography, blood pressure, and interdialytic weight gain (IDWG) were measured.
Main Results:
- Individualized sodium significantly reduced blood pressure and IDWG in hypertensive patients (p=0.018).
- Normotensive patients showed a significant decrease in IDWG (p=0.004).
- Increased sodium gradient correlated with higher LVDD, and increased IDWG correlated with higher LVM.
Conclusions:
- Reducing dialysate sodium based on pre-HD levels improves blood pressure and fluid management.
- This strategy mitigates cardiac volume overload and reduces heart hypertrophy in hemodialysis patients.
Abstract:
Aims: This study assessed the effects of individualized dialysis sodium prescription on changes of echo-cardiography in hemodialysis (HD) patients. Methods: 77 chronic hemodialysis patients were analysed. In the first phase all patients underwent dialysis with standard dialysate sodium of 138 mmol/L followed by the second phase where dialysis was performed with individualized dialysate sodium concentration according to average pre HD serum sodium concentration. After the first phase, the subjects were divided into 3 groups: normotensive, hypertensive and hypotensive based on the average pre-HD systolic BP during the first phase. In all patients echocardiography was performed at the end of the first and second phase. Results: Patients had no statistical significant change in blood pressure compared with standard dialysate sodium, only statistical significant change in interdialytic weight gain (IDWG). By dividing the patients, sodium individualization resulted in significantly lower blood pressure and IDWG (p=0.018) in hyper-tensive patients, whereas normotensive patients showed only significant decrease in IDWG (p=0,004). Hypertensive patients had significant highest sodium gradient compared to other patients (p<0.05), followed by significant increase of 0,6% IDWG confirmed with univariate regression analysis. In all patients, echocardiography analysis showed an increase of 2.04 mm of LVDD by increasing the sodium gradient for 1 mmol/L and significantly increased LVM of 35.69 gr by 1 kg increase in IDWG. Conclusions: A reduction of the dialysate sodium concentration based on the pre HD serum sodium level of the patient, reduced the SBP, DBP and IDWG and decreased the volume overload upon the heart and consequently heart hypertrophy assessed by echocardiography.
Related Concept Videos
Heart Failure Drugs: Diuretics
Chronic Kidney Disease IV: Nursing Management
Heart Failure VI: Adjunct Therapies
Hemodialysis II: Procedure and Complications
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Heart Failure II: Pathophysiology


